I think this concern was addressed in the article. The more advanced version of the idea would have wealthy donors fund studies, then receive the drug on a com

I think this concern was addressed in the article. The more advanced version of the idea would have wealthy donors fund studies, then receive the drug on a compassionate basis alongside the study, rather than actually participating in it. (There was a bit more detail to give the drug companies maximum liability coverage, but that was the basic idea.)